Synaptics (SYNA) director acquires 3,036 shares; holdings 21,657

Q: What did Synaptics (SYNA) report in this Form 4?

A director acquired 3,036 common shares on 11/03/2025 at $0, bringing direct holdings to 21,657 shares.

Q: How were the 3,036 Synaptics shares acquired?

They were acquired through restricted stock units (RSUs) that are vesting per the award’s schedule.

Q: What is the RSU vesting schedule for the Synaptics director?

One-fourth of the RSUs vest each quarter until fully vested on November 3, 2026, or on the date of the 2026 Annual Meeting if not standing for re‑election.

Q: What is the director’s ownership after the transaction?

Direct beneficial ownership is 21,657 Synaptics common shares.

Q: Was there a purchase price for the acquired shares?

The reported acquisition price was $0, consistent with RSU vesting rather than an open‑market purchase.

Q: What is the issuer’s ticker and name?

The issuer is Synaptics, Inc. with ticker SYNA.

Synaptics, Inc. (SYNA) disclosed an insider transaction on a Form 4.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Synaptics, Inc. (SYNA) disclosed an insider transaction on a Form 4. A company director acquired 3,036 shares of common stock on 11/03/2025 at a price of $0, increasing direct beneficial ownership to 21,657 shares.

The acquisition reflects vesting of restricted stock units (RSUs), which are scheduled to vest quarterly until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the Issuer’s 2026 Annual Meeting of Stockholders.

Insider Trade Summary

Grant/Award: 3,036 shares

Grant/Award 1 txn

Insider Buchanan Jeffrey

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,036	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,657 shares (Direct)

Footnotes (1)

F1. One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.

FAQ

What did Synaptics (SYNA) report in this Form 4?

A director acquired 3,036 common shares on 11/03/2025 at $0, bringing direct holdings to 21,657 shares.

How were the 3,036 Synaptics shares acquired?

They were acquired through restricted stock units (RSUs) that are vesting per the award’s schedule.

What is the RSU vesting schedule for the Synaptics director?

One-fourth of the RSUs vest each quarter until fully vested on November 3, 2026, or on the date of the 2026 Annual Meeting if not standing for re‑election.

What is the director’s ownership after the transaction?

Direct beneficial ownership is 21,657 Synaptics common shares.

Was there a purchase price for the acquired shares?

The reported acquisition price was $0, consistent with RSU vesting rather than an open‑market purchase.

What is the issuer’s ticker and name?

The issuer is Synaptics, Inc. with ticker SYNA.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 11/04/2025 - 04:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buchanan Jeffrey

(Last)

(First)

(Middle)

1109 MCKAY DRIVE

(Street)

SAN JOSE

95131

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/03/2025		A		3,036⁽¹⁾	A	$0	21,657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.

Remarks:

	/s/ Pamela Fields, as attorney-in-fact	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR